American Health Packaging Recalls Oxycodone Hydrochloride Tablets Due to Defective Blister Seals
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Amerisource Health Services LLC has recalled 31,676 packages of Oxycodone Hydrochloride tablets due to defective blister card seals that allow tablets to fall out of their packaging.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, drugs.
What Happened
Amerisource Health Services LLC has initiated a voluntary Class II recall of Oxycodone Hydrochloride Tablets, USP (CII), 5 mg. The recall follows multiple customer reports of defective container seals. Specifically, the blister cards were found to have weak or non-existent seals, causing tablets to fall out of their individual cavities.
Which Products Are Affected
The recall affects the following product distributed nationwide in the United States:
- Product Name: Oxycodone Hydrochloride Tablets, USP (CII), 5 mg
- Packaging: 100-Count (10 x 10) blister cards per carton
- NDC Number: 68084-354-01
- Affected Lots: 1027932 (Expiration 06/30/2027) and 1028360 (Expiration 08/31/2027)
- Quantity: 31,676 packages
- Manufacturer: American Health Packaging (Columbus, Ohio)
What You Should Do
Consumers, pharmacists, and healthcare providers should immediately inspect their stock for the affected lot numbers. Amerisource Health Services LLC initiated the notification process via letter on January 14, 2026. If you possess the recalled product, follow the instructions provided in the notification letter for returns and handling.
Why This Matters
Defective packaging for prescription medications can lead to compromised product integrity or accidental ingestion if tablets are separated from their labeled containers and secure blister cards.
Source
Information provided by the FDA under recall number D-0338-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.